To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
CereVasc fetches $43.9m Series A
CereVasc Inc, a medical device company that focuses on treating patients with hydrocephalus, has raised $43.9 million in Series A financing.
